Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography
Non-Invasive Peripheral Arterial Tonometry (EndoPAT) Increases Diagnostic Yield of Coronary Artery Disease by Coronary Angiography
1 other identifier
observational
201
1 country
1
Brief Summary
The purpose of this study is to assess the non-invasive, Peripheral Arterial Tonometry (PAT) testing as another way of predicting potential coronary artery blockages in the heart.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 22, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedFirst Posted
Study publicly available on registry
April 20, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedJune 25, 2014
June 1, 2014
1.6 years
November 22, 2011
June 24, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
To determine if the assessment of endothelial function by non-invasive peripheral arterial tonometry improves diagnostic yield of elective coronary angiography
Will compare the score of the EndoPAT test to the outcome of the angiogram to determine if the score is predictive of coronary artery disease.
same day as the angiogram
Study Arms (1)
Patients having a first time angiogram
Patients who are coming to the Cardiac Cath Lab to have an angiogram for the first time
Eligibility Criteria
Patients coming to the Cardiac Cath Lab to determine if they have coronary artery disease
You may qualify if:
- Patients without known coronary disease who are referred for coronary angiography.
- Adults 18 years and older.
You may not qualify if:
- Patients with known coronary disease, acute coronary syndrome, cardiac transplantation, and severe connective tissue disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- Itamar-Medical, Israelcollaborator
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amir Lerman, B.D.
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Principal Investigator
Study Record Dates
First Submitted
November 22, 2011
First Posted
April 20, 2012
Study Start
September 1, 2010
Primary Completion
April 1, 2012
Study Completion
June 1, 2014
Last Updated
June 25, 2014
Record last verified: 2014-06